Literature DB >> 6300193

Bioconversion of C-6 sulfidopeptide leukotrienes by the responding guinea pig ileum determines the time course of its contraction.

S Krilis, R A Lewis, E J Corey, K F Austen.   

Abstract

The naturally occurring sulfidopeptide leukotrienes, leukotriene (LT) C(4) (LTC(4)) [5(S)-hydroxy - 6(R) - S - glutathionyl - 7,9 - trans, 11,14 - cis - eicosatetraenoic acid] and its cysteinylglycine (LTD(4)) and cysteinyl (LTE(4)) analogs, which are derived by peptide cleavage, differ in the concentrations required to elicit comparable contractions of the guinea pig ileum, with respective potencies of 1.2:5:1. The effect of the ongoing bioconversion of LTC(4) and LTD(4) on the contractile response of the guinea pig ileum to each was determined by recording the pattern of the contraction and quantitating the initial agonist and its metabolic products. The contraction was elicited by radiolabeled agonist, and its conversion products were sampled at defined intervals and resolved by their retention times on reverse-phase high performance liquid chromatography. After a latent period of 60 s. LTC(4) initiated a linear response, followed by a slower, progressive response to a maximum level that was maintained without relaxation. The metabolic conversion of LTC(4) was <5% during the linear phase of contraction and complete inhibition of bioconversion of LTC(4) to LTD(4) by the presence of serine-borate complex did not alter the pattern of the spasmogenic response. As the maximum response in the presence of serine-borate complex was three-quarters of that obtained without the inhibitor of bioconversion, the predominant response was to LTC(4) itself. The spasmogenic response of the ileum to LTD(4) was immediate, linear to a maximum level, and immediately followed by a marked relaxation. That the failure of LTD(4) to sustain a contraction was due to its immediate, rapid, and quantitative conversion to the less potent LTE(4) was established by pharmacologically inhibiting and anatomically deleting the converting activity. In the presence of L-cysteine the conversion of LTD(4) to LTE(4) was largely inhibited and the maximum contractile response was well maintained. After anatomic removal of the mucosa that contained the LTD(4) dipeptidase activity, the longitudinal smooth muscle preparation gave a maximal response to LTD(4) that was fully maintained. Thus, bioconversion is not a prerequisite for the spasmogenic activity of LTC(4) and accounts for the transient response of the ileum to LTD(4).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6300193      PMCID: PMC436948          DOI: 10.1172/jci110845

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Leukotriene D: a slow reacting substance from rat basophilic leukemia cells.

Authors:  L Orning; S Hammarström; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

2.  Identification of the C(6)-S-conjugate of leukotriene A with cysteine as a naturally occurring slow reacting substance of anaphylaxis (SRS-A). Importance of the 11-cis-geometry for biological activity.

Authors:  R A Lewis; J M Drazen; K F Austen; D A Clark; E J Corey
Journal:  Biochem Biophys Res Commun       Date:  1980-09-16       Impact factor: 3.575

3.  Structure of slow-reacting substance of anaphylaxis from guinea-pig lung.

Authors:  H R Morris; G W Taylor; P J Piper; J R Tippins
Journal:  Nature       Date:  1980-05-08       Impact factor: 49.962

4.  Serine-borate complex as a transition-state inhibitor of gamma-glutamyl transpeptidase.

Authors:  S S Tate; A Meister
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

5.  Leukotriene A. Isolation from human polymorphonuclear leukocytes.

Authors:  O Rådmark; C Malmsten; B Samuelsson; G Goto; A Marfat; E J Corey
Journal:  J Biol Chem       Date:  1980-12-25       Impact factor: 5.157

6.  The effects of adrenaline, noradrenaline and isoprenaline on inhibitory alpha- and beta-adrenoceptors in the longitudinal muscle of the guinea-pig ileum.

Authors:  H W Kosterlitz; R J Lydon; A J Watt
Journal:  Br J Pharmacol       Date:  1970-06       Impact factor: 8.739

7.  Leukotriene C: a slow-reacting substance from murine mastocytoma cells.

Authors:  R C Murphy; S Hammarström; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

8.  Slow reacting substances of anaphylaxis: identification of leukotrienes C-1 and D from human and rat sources.

Authors:  R A Lewis; K F Austen; J M Drazen; D A Clark; A Marfat; E J Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

9.  Inhibition of leukotriene C and leukotriene D biosynthesis.

Authors:  L Orning; S Hammarström
Journal:  J Biol Chem       Date:  1980-09-10       Impact factor: 5.157

10.  Leukotrienes are potent constrictors of human bronchi.

Authors:  S E Dahlén; P Hedqvist; S Hammarström; B Samuelsson
Journal:  Nature       Date:  1980-12-04       Impact factor: 49.962

View more
  14 in total

Review 1.  The leukotriene E4 puzzle: finding the missing pieces and revealing the pathobiologic implications.

Authors:  K Frank Austen; Akiko Maekawa; Yoshihide Kanaoka; Joshua A Boyce
Journal:  J Allergy Clin Immunol       Date:  2009-08-03       Impact factor: 10.793

2.  Dectin-2 regulates the effector phase of house dust mite-elicited pulmonary inflammation independently from its role in sensitization.

Authors:  Matthew W Parsons; Li Li; Aaron M Wallace; Min Jung Lee; Howard R Katz; James M Fernandez; Shinobu Saijo; Yoichiro Iwakura; K Frank Austen; Yoshihide Kanaoka; Nora A Barrett
Journal:  J Immunol       Date:  2014-01-22       Impact factor: 5.422

3.  Stimulation by leukotriene D4 of increases in the cytosolic concentration of calcium in dimethylsulfoxide-differentiated HL-60 cells.

Authors:  L Baud; E J Goetzl; C H Koo
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

Review 4.  New developments concerning leukotriene antagonists: a review.

Authors:  J H Musser; A F Kreft; A J Lewis
Journal:  Agents Actions       Date:  1986-06

Review 5.  The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology.

Authors:  R A Lewis; K F Austen
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

6.  Vascular responses to leukotriene B4, C4 and D4 following FPL 55712, indomethacin, saralasin, phentolamine and verapamil in the conscious rat.

Authors:  J Filep; E Földes-Filep; J C Frölich
Journal:  Br J Pharmacol       Date:  1987-02       Impact factor: 8.739

7.  Leukotriene E4-induced airway hyperresponsiveness of guinea pig tracheal smooth muscle to histamine and evidence for three separate sulfidopeptide leukotriene receptors.

Authors:  T H Lee; K F Austen; E J Corey; J M Drazen
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

8.  Specific binding of leukotriene C4 to ileal segments and subcellular fractions of ileal smooth muscle cells.

Authors:  S Krilis; R A Lewis; E J Corey; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

9.  Cysteinyl leukotriene 2 receptor on dendritic cells negatively regulates ligand-dependent allergic pulmonary inflammation.

Authors:  Nora A Barrett; James M Fernandez; Akiko Maekawa; Wei Xing; Li Li; Matthew W Parsons; K Frank Austen; Yoshihide Kanaoka
Journal:  J Immunol       Date:  2012-09-21       Impact factor: 5.422

10.  The role of blood vessels in the bioconversion of leukotrienes in the pig.

Authors:  S A Galton; P J Piper
Journal:  Br J Pharmacol       Date:  1987-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.